EAGAN, Minn.--(BUSINESS WIRE)--Biothera Pharmaceuticals Inc. today announced that Barry Labinger, Chief Executive Officer, will present at the 3rd Annual Jefferies Immuno-Oncology Summit on Friday, April 8, 2016 at 1:15 p.m. Eastern Time in Boston, Mass. Mr. Labinger will provide an overview of Biothera and its clinical development plans in oncology.
